ATP2B4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.395200E-01
Normal-vs-Stage2
5.762200E-01
Normal-vs-Stage3
8.676200E-01
Normal-vs-Stage4
3.094600E-01
Stage1-vs-Stage2
8.369800E-01
Stage1-vs-Stage3
7.259600E-01
Stage1-vs-Stage4
5.217800E-01
Stage2-vs-Stage3
6.399000E-01
Stage2-vs-Stage4
7.318200E-01
Stage3-vs-Stage4
4.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.518800E-01
Normal-vs-AfricanAmerican
6.246400E-01
Normal-vs-Asian
4.644200E-01
Caucasian-vs-AfricanAmerican
8.878000E-01
Caucasian-vs-Asian
2.234200E-01
AfricanAmerican-vs-Asian
4.800200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.017000E-01
Normal-vs-Female
6.321400E-01
Male-vs-Female
7.459000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.209000E-01
Normal-vs-Age(41-60Yrs)
4.089600E-01
Normal-vs-Age(61-80Yrs)
6.714000E-01
Normal-vs-Age(81-100Yrs)
9.098400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.491800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.984200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.526400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.124200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.525570E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.592200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.634600E-01
Normal-vs-Daily Drinker
8.057600E-01
Normal-vs-Weekly Drinker
4.547400E-01
Normal-vs-Occasional Drinker
2.584000E-01
Normal-vs-Social Drinker
6.483800E-01
Non Drinker-vs-Daily Drinker
7.596600E-01
Non Drinker-vs-Weekly Drinker
1.792170E-01
Non Drinker-vs-Occasional Drinker
1.934370E-02
Non Drinker-vs-Social Drinker
3.924800E-01
Daily Drinker-vs-Weekly Drinker
4.121600E-01
Daily Drinker-vs-Occasional Drinker
1.035420E-01
Daily Drinker-vs-Social Drinker
4.989000E-01
Weekly Drinker-vs-Occasional Drinker
4.678400E-01
Weekly Drinker-vs-Social Drinker
8.782400E-01
Occasional Drinker-vs-Social Drinker
7.575600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.261800E-01
Normal-vs-Grade 2
6.759900E-02
Normal-vs-Grade 3
1.132160E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.944200E-02
Grade 1-vs-Grade 3
1.828150E-01
Grade 1-vs-Grade 4
2.261800E-01
Grade 2-vs-Grade 3
3.185400E-01
Grade 2-vs-Grade 4
6.759900E-02
Grade 3-vs-Grade 4
1.132160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.798600E-01
Normal-vs-NonDiabetic
6.019000E-01
Diabetic-vs-NonDiabetic
8.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.275600E-01
Normal-vs-NoPancreatitis
6.411600E-01
Pancreatitis-vs-NoPancreatitis
3.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.158400E-01
Normal-vs-N1
5.975600E-01
N0-vs-N1
2.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.939000E-01
Normal-vs-TP53-NonMutant
9.191800E-01
TP53-Mutant-vs-TP53-NonMutant
5.041700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
